Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ION775 in Adults With Hypertriglyceridemia
NCT07604974Phase 2Recruiting
- Sponsor
- Ionis Pharmaceuticals
- Start
- May 2026
- Primary completion
- Sep 2027
- Modality
- Conjugated siRNA, Chemically Modified siRNA
- Countries
- 2
01
Overview
A Phase 2 trial of ION775 in hypertriglyceridemia, sponsored by Ionis Pharmaceuticals. Started May 2026; status: recruiting.
02
Drugs
ION775
03
Conditions
hypertriglyceridemia
Beyond the preview
Go deeper on NCT07604974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07604974.